Vivos Therapeutics Inc
Research Vivos Therapeutics Inc (VVOS) on Bullrun: market cap USD 3.68M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVVOS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 3.68M
- Financial periodQ1 2026
- RevenueUSD 5.14M
- Net income-USD 7.75M
- Free cash flow-USD 6.03M
- Gross margin59.5%
Valuation Snapshot
latest market cap is USD 3.68M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 17.44M | -USD 21.17M | -USD 17.60M | 60.4% | -2.07 | USD 2.03M | USD 8.82M | -USD 1.49M |
| FY2024 | USD 15.03M | -USD 11.14M | -USD 13.26M | 60.0% | -2.22 | USD 6.26M | USD 1.51M | USD 7.95M |
| FY2023 | USD 13.80M | -USD 13.58M | -USD 12.75M | 59.9% | -11.14 | USD 1.64M | USD 2.00M | USD 411.00K |
| FY2022 | USD 16.02M | -USD 23.85M | -USD 20.51M | 62.5% | -25.9 | USD 3.52M | USD 2.91M | USD 4.80M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 3.68M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 18.85M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 25.27M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 16.57M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 9.25M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 51.78M | n/a | n/a | n/a |
About Vivos Therapeutics Inc
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Vivos Therapeutics Inc's market cap?
Vivos Therapeutics Inc's market capitalization is USD 3.68M.
What does Vivos Therapeutics Inc do?
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children.